tiprankstipranks
Advertisement
Advertisement

ANL Stock Latest News

Leerink bullish on Adlai Nortye, initiates with an Outperform
The FlyLeerink bullish on Adlai Nortye, initiates with an Outperform
7d ago
ANL
Adlai Nortye initiated with an Outperform at Leerink
PremiumThe Fly
Adlai Nortye initiated with an Outperform at Leerink
7d ago
ANL
Adlai Nortye files to sell $600M of Class A ordinary shares
PremiumThe Fly
Adlai Nortye files to sell $600M of Class A ordinary shares
17d ago
ANL
Adlai Nortye files to sell 64.62M Class A ordinary shares for holders
PremiumThe Fly
Adlai Nortye files to sell 64.62M Class A ordinary shares for holders
17d ago
ANL
Adlai Nortye upgraded to Buy at H.C. Wainwright as AN9025 enters clinic
PremiumThe Fly
Adlai Nortye upgraded to Buy at H.C. Wainwright as AN9025 enters clinic
1M ago
ANL
Adlai Nortye upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyAdlai Nortye upgraded to Buy from Neutral at H.C. Wainwright
1M ago
ANL
Adlai Nortye Doses First Patient in Global Phase 1 Trial of Pan-RAS Inhibitor AN9025
Premium
Company Announcements
Adlai Nortye Doses First Patient in Global Phase 1 Trial of Pan-RAS Inhibitor AN9025
1M ago
6K
ANL
Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline
Premium
Company Announcements
Adlai Nortye Secures $140 Million PIPE Financing to Support Oncology Pipeline
2M ago
6K
ANL
Adlai Nortye prices 64.6M shares at $2.17 in private placement
PremiumThe Fly
Adlai Nortye prices 64.6M shares at $2.17 in private placement
2M ago
ANL
Adlai Nortye Ltd (ADR) trading resumes
PremiumThe Fly
Adlai Nortye Ltd (ADR) trading resumes
2M ago
ANL
Adlai Nortye Ltd (ADR) trading halted, volatility trading pause
PremiumThe Fly
Adlai Nortye Ltd (ADR) trading halted, volatility trading pause
2M ago
ANL
Adlai Nortye initiated with a Buy at Lucid Capital
PremiumThe Fly
Adlai Nortye initiated with a Buy at Lucid Capital
2M ago
ANL
Adlai Nortye Narrows First-Half 2025 Loss as Oncology Pipeline Advances
PremiumCompany AnnouncementsAdlai Nortye Narrows First-Half 2025 Loss as Oncology Pipeline Advances
3M ago
6K
ANL
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China
Premium
Company Announcements
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China
3M ago
6K
ANL
Adlai Nortye enters exclusive license agreement with ASK Pharm for AN9025
Premium
The Fly
Adlai Nortye enters exclusive license agreement with ASK Pharm for AN9025
3M ago
ANL
Adlai Nortye Ltd. Shareholders Approve Redomiciliation to Singapore
PremiumCompany Announcements
Adlai Nortye Ltd. Shareholders Approve Redomiciliation to Singapore
4M ago
6K
ANL
Adlai Nortye Ltd. Plans Redomiciliation to Singapore
PremiumCompany Announcements
Adlai Nortye Ltd. Plans Redomiciliation to Singapore
5M ago
6K
ANL
Adlai Nortye Ltd. Announces 2025 Share Incentive Plan and Board Changes
PremiumCompany Announcements
Adlai Nortye Ltd. Announces 2025 Share Incentive Plan and Board Changes
9M ago
6K
ANL
Adlai Nortye downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Adlai Nortye downgraded to Neutral from Buy at H.C. Wainwright
10M ago
ANL
Adlai Nortye downgraded at H.C. Wainwright after ‘unfortunate’ trial miss
PremiumThe FlyAdlai Nortye downgraded at H.C. Wainwright after ‘unfortunate’ trial miss
10M ago
ANL
Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results
Premium
Company Announcements
Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results
10M ago
6K
ANL
Adlai Nortye Announces Change in Auditing Firm
Premium
Company Announcements
Adlai Nortye Announces Change in Auditing Firm
1y ago
6K
ANL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >